Related Experiment Video
Updated: Jan 23, 2026

Pooled CRISPR-Based Genetic Screens in Mammalian Cells
Published on: September 4, 2019
Importance of genetic screens in precision oncology
Antonio Mulero-Sánchez1, Ziva Pogacar1, Loredana Vecchione2
1Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Abstract:
Precision oncology aims to distinguish which patients are eligible for a specific treatment in order to achieve the best possible outcome. In the last few years, genetic screens have shown their potential to find the new targets and drug combinations as well as predictive biomarkers for response and/or resistance to cancer treatment. In this review, we outline how precision oncology is changing over time and describe the different applications of genetic screens. Finally, we present some practical examples that describe the utility and the limitations of genetic screens in precision oncology.
Insights
Genetic screens are revolutionizing precision oncology by identifying new cancer treatment targets and biomarkers. This review explores their evolving applications and practical utility in tailoring therapies for better patient outcomes.
Area of Science:
- Oncology
- Genetics
- Pharmacology
Background:
- Precision oncology aims to personalize cancer treatment for optimal outcomes.
- Genetic screens have emerged as powerful tools in cancer research.
- Identifying predictive biomarkers is crucial for treatment selection.
Purpose of the Study:
- To review the evolving landscape of precision oncology.
- To describe the diverse applications of genetic screens in cancer research.
- To illustrate the utility and limitations of genetic screens through practical examples.
Main Methods:
- Literature review of precision oncology and genetic screening methodologies.
- Analysis of genetic screening applications in identifying therapeutic targets.
- Examination of genetic screens for predicting treatment response and resistance.
Main Results:
- Genetic screens facilitate the discovery of novel drug targets and combinations.
- Biomarkers for treatment response and resistance can be identified using genetic screens.
- The review highlights practical case studies demonstrating the impact of genetic screens.
Conclusions:
- Genetic screens are integral to advancing precision oncology.
- Understanding the utility and limitations of genetic screens is key for clinical implementation.
- Continued research in genetic screening will further refine personalized cancer therapies.
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Uncertainty in Measurement: Accuracy and Precision
Genetics of Speciation
What is Population Genetics?
What is Genetic Engineering?
Accuracy and Precision

